Company record
Shenzhen Techdow Pharmaceutical Co., Ltd.
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Shenzhen Techdow Pharmaceutical Co., Ltd..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Oct 28 | Class II | Shenzhen Techdow Pharmaceutical Co., Ltd. Drug |
Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01 Lack of Assurance of Sterility |